Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Marzo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Brain : a Journal of Neurology|December 3, 1999
Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion moleculesI Durán, E M Martínez-Cáceres, J Río, et al.
Neurologia (Barcelona, Spain)|June 10, 2000
[Campylobacter coli-related meningitis in an adult male]M E Marzo Sola, M Otal Castán, I Hernando de la Bárcena, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|September 4, 2003
[Coma and respiratory insufficiency after fracture of femur and tibia]M Repiso Moreno, J L Peña Somovilla, A Moreno Origosa, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|August 14, 1999
Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sisterJ R Ara, E Mayayo, M E Marzo, et al.
Neurologia (Barcelona, Spain)|November 1, 1995
[Neurobrucellosis. A report of 13 cases]M E Marzo Sola, C Calderón Girón, T Ayuso Blanco, et al.
Revista De Neurologia|July 1, 1996
[Phenotype variability in adrenoleukodystrophy. Presentation of three new cases and a review of literature]J R Ara, F J Carod, J M Errea, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja]T Ayuso, M E Marzo-Sola, T Castillo-Trivino, et al.
Plos One|October 13, 2021
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registryJ E Meca-Lallana, C Oreja-Guevara, D Muñoz, et al.
Revista De Neurologia|July 27, 2018
[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study]J Mallada-Frechin, V Meca-Lallana, F Barrero, et al.
Neurologia|January 18, 2024
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023J E Meca-Lallana, S Martínez Yélamos, S Eichau, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Brain : a Journal of Neurology|December 3, 1999
Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion moleculesI Durán, E M Martínez-Cáceres, J Río, et al.
Neurologia (Barcelona, Spain)|June 10, 2000
[Campylobacter coli-related meningitis in an adult male]M E Marzo Sola, M Otal Castán, I Hernando de la Bárcena, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|September 4, 2003
[Coma and respiratory insufficiency after fracture of femur and tibia]M Repiso Moreno, J L Peña Somovilla, A Moreno Origosa, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|August 14, 1999
Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sisterJ R Ara, E Mayayo, M E Marzo, et al.
Neurologia (Barcelona, Spain)|November 1, 1995
[Neurobrucellosis. A report of 13 cases]M E Marzo Sola, C Calderón Girón, T Ayuso Blanco, et al.
Revista De Neurologia|July 1, 1996
[Phenotype variability in adrenoleukodystrophy. Presentation of three new cases and a review of literature]J R Ara, F J Carod, J M Errea, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja]T Ayuso, M E Marzo-Sola, T Castillo-Trivino, et al.
Plos One|October 13, 2021
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registryJ E Meca-Lallana, C Oreja-Guevara, D Muñoz, et al.
Revista De Neurologia|July 27, 2018
[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study]J Mallada-Frechin, V Meca-Lallana, F Barrero, et al.
Neurologia|January 18, 2024
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023J E Meca-Lallana, S Martínez Yélamos, S Eichau, et al.
Pageof 3